Cryo Rib Fracture Study

ConditionRib Fractures
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Minnesota

About this trial

The purpose of this study is to determine if patients with rib fractures who undergo cryoablation of the intercostal nerves have improved pain control 7 days from procedure when compared to those who have a ESP catheter.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who are over 18 who have more than one ribs fractured.

Disqualifiers

Patients who have an exclusion to regional anesthesia.

Patients who are pregnant via self-report or pregnancy test if they take one.

Non-English speakers

Patients who have cold urticaria

Trial design

Design model

Parallel

Treatments tested in this trial

  • Cryoablation

    Drug

    an injection of 1ml of 1% lidocaine per rib and ultrasound guided cryoablation of the intercostal nerves

  • ESP Catheter

    Drug

    an ultrasound guided erector spinae plane catheter with initial bolus of 30 mL of 0.25% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour via programmed intermittent bolus.

Treatment groups

48 Participants
are divided into 2 treatment groups
Group A: CryoablationExperimental treatment 1 intervention
Group B: ESP catheterActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Maximum pain score on POD (Post Operative Day) 7

Maximum pain score on POD (Post Operative Day) 7

Time frame
7 days post procedure
2

Opioid Use

Opioid Use measured in MMEs

Time frame
30 days post procedure
3

Functional Pain Scores

Functional Pain Scores on POD 0,1,2,3,4,5,6,7,and 30

Time frame
30 days post procedure
4

Number of Patients using opioids at POD 30

, Number of Patients using opioids at POD 30

Time frame
30 days post procedure

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.